|
1. |
Specialized nutrition support in critically ill patients |
|
Current Opinion in Critical Care,
Volume 9,
Issue 4,
2003,
Page 249-259
Richard Griffiths,
Preview
|
PDF (516KB)
|
|
摘要:
How nutritional therapy may affect real clinical outcomes is not readily apparent from a superficial reading of current data. Despite great claims in reducing infectious incidence, many studies show little difference in meaningful clinical outcomes. This has led to confusion over the role of nutrition and nutrition practice in intensive care. However, the role that nutrition plays in preventing infection and later how nutrition aids long-term recovery perhaps explain many of the misconceptions and difficulty in understanding the evidence. Encouraging new evidence is starting to show that outcome can be improved by implementing relatively simple therapies well that have an impact on nutrition and metabolic control.
ISSN:1070-5295
出版商:OVID
年代:2003
数据来源: OVID
|
2. |
Treatment of metabolic acidosis |
|
Current Opinion in Critical Care,
Volume 9,
Issue 4,
2003,
Page 260-265
Jacques Levraut,
Dominique Grimaud,
Preview
|
PDF (299KB)
|
|
摘要:
Metabolic acidosis is characterized by a decrease of the blood pH associated with a decrease in the bicarbonate concentration. This may be secondary to a decrease in the strong ion difference or to an increase in the weak acids concentration, mainly the inorganic phosphorus. From a conceptual point of view, two types of nontoxic metabolic acidosis must be differentiated: the mineral metabolic acidosis that reveals the presence of an excess of nonmetabolizable anions, and the organic metabolic acidosis that reveals an excess of metabolizable anions. Significance and consequences of these two types of acidosis are radically different. Mineral acidosis is not caused by a failure in the energy metabolic pathways, and its treatment is mainly symptomatic by correcting the blood pH (alkali therapy) or accelerating the elimination of excessive mineral anions (renal replacement therapy). On the other hand, organic acidosis gives evidence that a severe underlying metabolic distress is in process. No reliable argument exists to prove that this acidosis is harmful under these conditions in humans. Experimental data even show that hypoxic cells are able to survive only if the medium is kept acidic. The management of an acute organic metabolic acidosis is therefore primarily based on the cause of the acidosis, and no scientific argument exists to justify the correction of the acid–base imbalance in this context.
ISSN:1070-5295
出版商:OVID
年代:2003
数据来源: OVID
|
3. |
Antioxidant therapy in intensive care |
|
Current Opinion in Critical Care,
Volume 9,
Issue 4,
2003,
Page 266-270
Robin Lovat,
Jean-Charles Preiser,
Preview
|
PDF (261KB)
|
|
摘要:
Purpose of reviewThis review intends to summarize the recent findings regarding the presence of increased oxidative stress in critically ill patients and its potential pathophysiologic role, as well as the results of recent clinical trials of antioxidant therapies.Recent findingsSeveral lines of evidence confirm the increase in oxidative stress during critical illness. The oxidative damage to cells and tissues eventually contributes to organ failure. Prophylactic administration of antioxidant vitamins or glutamine, incorporated in the nutritional support or given as separate medications, efficiently attenuates the oxidative stress and in some studies improves the outcome of critically ill patients. Few data on the effects ofN-acetylcysteine or trace elements have been published during the last two years.SummaryPatients at risk of organ failure could benefit from the early adjunction of antioxidant treatment, including vitamins and glutamine.
ISSN:1070-5295
出版商:OVID
年代:2003
数据来源: OVID
|
4. |
Metabolic alterations in sepsis and vasoactive drug–related metabolic effects |
|
Current Opinion in Critical Care,
Volume 9,
Issue 4,
2003,
Page 271-278
Karl Träger,
Daniel DeBacker,
Peter Radermacher,
Preview
|
PDF (657KB)
|
|
摘要:
The main clinical characteristics of sepsis and septic shock are derangements of cardiocirculatory and respiratory function. Additionally, profound alterations in metabolic pathways occur leading to hypermetabolism, enhanced energy expenditure, and insulin resistance. The clinical hallmarks are hyperglycemia, hyperlactatemia, and enhanced protein catabolism. These metabolic alterations are even more pronounced during sepsis as a result of cytokine release and subsequent induction of inflammatory pathways. Increased oxygen demands from mitochondrial oxygen utilization and oxygen consumption related to oxygen radical formation may contribute to hypermetabolism. In addition, mitochondrial dysfunction with impaired cellular respiration may be present. Mainstay therapeutic interventions for hemodynamic stabilization are adequate volume resuscitation and vasoactive agents, which, however, have additional impact on metabolic activity. Therefore, beyond hemodynamic effects, specific drug-related metabolic alterations need to be considered for optimal treatment during sepsis. This review gives an overview of the typical metabolic alterations during sepsis and septic shock and highlights the impact of vasoactive therapy on metabolism.
ISSN:1070-5295
出版商:OVID
年代:2003
数据来源: OVID
|
5. |
Glutamine and acute illness |
|
Current Opinion in Critical Care,
Volume 9,
Issue 4,
2003,
Page 279-285
Jan Wernerman,
Preview
|
PDF (346KB)
|
|
摘要:
This is a literature review over a time period of the past 2 years concerning glutamine in clinical nutrition. Emphasis is put upon studies of glutamine in clinical settings, but a brief overview of the large range of literature over the role of glutamine in various experimental settings is also included. The most interesting concept for the past 2 years is the suggestion to use plasma glutamine concentration at admission to the intensive care unit as a prognostic marker and as a possible indicator for indication of glutamine supplementation.
ISSN:1070-5295
出版商:OVID
年代:2003
数据来源: OVID
|
6. |
Antimicrobial strategies in surgical critical care |
|
Current Opinion in Critical Care,
Volume 9,
Issue 4,
2003,
Page 286-291
Scott Imahara,
Avery Nathens,
Preview
|
PDF (340KB)
|
|
摘要:
There is clear evidence that early and appropriate empiric antimicrobial therapy for suspected nosocomial infections reduces the rate of adverse outcomes. This approach necessitates a liberal antimicrobial policy, whereas observational and experimental data also suggest that excessive antibiotic use promotes the emergence of antimicrobial resistance, creating a dilemma for the intensivists and begging the question as to whether minimization of antimicrobial resistance and maximization of individual patient outcomes are mutually exclusive. Contemporary strategies are outlined for the antimicrobial management of ventilator-associated pneumonia, the most common nosocomial infection in the intensive care unit, and the use of institution-specific guidelines, invasive diagnostic approaches, and other objective criteria to ensure adequate, yet not excessive use of antimicrobials are discussed. The focus is then on relative merits of routine antifungal prophylaxis as an example of an attempt to reduce the incidence and adverse consequences of late diagnoses of fungal sepsis. Finally, the advantages and disadvantages of antimicrobial cycling as a means of reducing antimicrobial resistance in the intensive care unit are outlined.
ISSN:1070-5295
出版商:OVID
年代:2003
数据来源: OVID
|
7. |
Goal-oriented shock resuscitation for major torso trauma: What are we learning? |
|
Current Opinion in Critical Care,
Volume 9,
Issue 4,
2003,
Page 292-299
Bruce McKinley,
Alicia Valdivia,
Frederick Moore,
Preview
|
PDF (410KB)
|
|
摘要:
Shock resuscitation is an obligatory intervention for severely injured patients who present in shock. During the past 15 years, with widespread acceptance of “damage control” surgery and early triage to the intensive care unit (ICU) to optimize resuscitation, the lives of many major trauma victims have been saved, and much has been learned about shock resuscitation. Due largely to the work of Shoemakeret al., a resuscitation strategy based on a standardized process using O2delivery index (DO2I) as an endpoint and physiologic performance goal for interventions has been developed, studied, and refined for resuscitation of shock caused by major trauma. DO2I ≥600 mL O2/min-m2is the only resuscitation endpoint variable that has been tested in prospective randomized trials (PRTs) of trauma patient outcome. These PRTs are limited, and their results are not conclusive. Results from other investigators, including our group, using similar process and endpoints, are indicating similar performance and outcomes. We believe that DO2I is a useful endpoint because it integrates three important variables,ie,hemoglobin concentration [Hb], arterial hemoglobin O2saturation, and cardiac output. We have found DO2I ≥500 mL O2/min-m2to be an endpoint with more general applicability, but we believe that the standardized process is more important than the specific endpoint. To standardize our process, we have developed a computerized decision support tool for shock resuscitation. This technology has provided novel data collection and has permitted refinement of the bedside process. Our data analysis indicates that the next challenge will be to develop a similar pre ICU resuscitation process that will use less invasive monitors and different endpoints. Identification of the high-risk resuscitation nonresponders early in the resuscitation process will be needed to redirect their clinical trajectories. As an endpoint for interventions for goal-directed resuscitation in the critically injured trauma patient, systemic O2delivery is the current state of the art and the basis for near future development of clinical processes for resuscitation of shock due to major trauma.
ISSN:1070-5295
出版商:OVID
年代:2003
数据来源: OVID
|
8. |
Controversy of immunonutrition for surgical critical-illness patients |
|
Current Opinion in Critical Care,
Volume 9,
Issue 4,
2003,
Page 300-305
Gordon Sacks,
Laurence Genton,
Kenneth Kudsk,
Preview
|
PDF (295KB)
|
|
摘要:
Specific nutrients such as arginine, glutamine, dietary nucleotides, and omega-3 fatty acids have been shown to influence infectious morbidity, antibiotic use, and hospital length of stay. The combination of these nutrients into one enteral formulation has become known as immune-enhancing diets. Consensus guidelines developed by a number of clinical investigators and published in 2001 concluded that immune-enhancing diets were beneficial in moderate to severely malnourished patients undergoing elective gastrointestinal surgery and patients sustaining severe blunt and penetrating torso trauma. The purpose of this article is to review data published between February 1, 2001, and January 31, 2003, to determine whether new studies substantiated or refuted the current recommendations for the use of immune-enhancing diets in surgical, critically injured, and critically ill patients. Results confirmed the benefits of preoperative administration of immune-enhancing diets in surgical patients but also demonstrated that postoperative administration offered no advantages. Decreased infectious complications were also observed in critically ill patients receiving immune-enhancing diets. Accumulating evidence supports the use of immune-enhancing diets in these specific patient populations.
ISSN:1070-5295
出版商:OVID
年代:2003
数据来源: OVID
|
9. |
Towards better care: an exploration of some barriers and solutions to research transfer in the intensive care unit |
|
Current Opinion in Critical Care,
Volume 9,
Issue 4,
2003,
Page 306-307
Derek Angus,
Preview
|
PDF (116KB)
|
|
ISSN:1070-5295
出版商:OVID
年代:2003
数据来源: OVID
|
10. |
Is the implementation of research findings in the critically ill hampered by the lack of universal definitions of illness? |
|
Current Opinion in Critical Care,
Volume 9,
Issue 4,
2003,
Page 308-315
Shannon Carson,
Andrew Shorr,
Preview
|
PDF (383KB)
|
|
摘要:
In the design of clinical trials, a clear definition of disease is essential for enrollment of a homogeneous study population with a higher likelihood of demonstrating a benefit of an intervention. A definition that is applicable to standard clinical practice enhances the ability of clinicians to apply results of the clinical trial to patient care. Use of a universally accepted definition allows valid comparisons across multiple studies. Sepsis, the acute respiratory distress syndrome, and ventilator-associated pneumonia are examples of conditions for which universal definitions developed by panels of experts have facilitated the design of successful clinical trials. However, implementation of the results of some of these studies has been complicated by a lack of understanding or acceptance of disease definitions or by their overly inclusive nature. For example, the presence of Systemic Inflammatory Response Syndrome (SIRS) will identify most patients with sepsis, however, a significant number of patients with those clinical findings will have other underlying processes. Approved definitions for VAP are cumbersome, and adherence to those definitions in the design of clinical trials is poor. This has led to confusion regarding the accuracy of diagnostic tests and poor acceptance of evidence based guidelines by clinicians. When investigators and clinicians do not adhere to common definitions of disease, results of clinical trials may be applied inappropriately or ignored altogether. More specific identifiers of critical illnesses using specific biochemical or genetic markers are being explored. This approach may also be useful for staging disease.
ISSN:1070-5295
出版商:OVID
年代:2003
数据来源: OVID
|
|